Torsten Westermeier

1.1k total citations
21 papers, 816 citations indexed

About

Torsten Westermeier is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Torsten Westermeier has authored 21 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Internal Medicine. Recurrent topics in Torsten Westermeier's work include Venous Thromboembolism Diagnosis and Management (6 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Torsten Westermeier is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (6 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Torsten Westermeier collaborates with scholars based in Germany, Canada and Austria. Torsten Westermeier's co-authors include Frank Misselwitz, Milen Minkov, Ajay K. Kakkar, Michael Gent, Michael R. Lassen, Bengt I. Eriksson, Nicole Grois, Helmut Gadner, Ulrike Pötschger and Martin Homering and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and CHEST Journal.

In The Last Decade

Torsten Westermeier

19 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torsten Westermeier Germany 14 310 261 231 156 125 21 816
Shankar Kumar United Kingdom 16 184 0.6× 171 0.7× 99 0.4× 19 0.1× 31 0.2× 43 813
Evangelos Messaris United States 15 534 1.7× 134 0.5× 40 0.2× 61 0.4× 41 0.3× 55 842
T Scholten Germany 12 238 0.8× 97 0.4× 79 0.3× 18 0.1× 18 0.1× 38 517
Rosario Sánchez‐Martínez Spain 14 129 0.4× 104 0.4× 140 0.6× 56 0.4× 79 0.6× 46 619
Dmytro Khadzhynov Germany 16 149 0.5× 190 0.7× 130 0.6× 24 0.2× 147 1.2× 31 936
Luigi Fenoglio Italy 14 275 0.9× 151 0.6× 215 0.9× 8 0.1× 106 0.8× 46 814
M. Zanazzi Italy 18 214 0.7× 117 0.4× 97 0.4× 23 0.1× 129 1.0× 69 911
Frank A. Baciewicz United States 15 243 0.8× 162 0.6× 40 0.2× 24 0.2× 27 0.2× 51 626
Laura M. Enomoto United States 18 265 0.9× 82 0.3× 26 0.1× 13 0.1× 36 0.3× 34 666
Gerardo Bozovich Argentina 9 153 0.5× 183 0.7× 34 0.1× 49 0.3× 35 0.3× 21 625

Countries citing papers authored by Torsten Westermeier

Since Specialization
Citations

This map shows the geographic impact of Torsten Westermeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Westermeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Westermeier more than expected).

Fields of papers citing papers by Torsten Westermeier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Westermeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Westermeier. The network helps show where Torsten Westermeier may publish in the future.

Co-authorship network of co-authors of Torsten Westermeier

This figure shows the co-authorship network connecting the top 25 collaborators of Torsten Westermeier. A scholar is included among the top collaborators of Torsten Westermeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torsten Westermeier. Torsten Westermeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarich, Troy C., Gary Peters, Scott D. Berkowitz, et al.. (2013). Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis‐mediated conditions. Annals of the New York Academy of Sciences. 1291(1). 42–55. 21 indexed citations
2.
Lassen, Michael R., Bengt I. Eriksson, Michael Gent, et al.. (2010). Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Thrombosis and Haemostasis. 105(3). 444–453. 207 indexed citations
3.
Turpie, Alexander G.G., Bengt I. Eriksson, Michael Gent, et al.. (2010). A POOLED ANALYSIS OF FOUR PIVOTAL STUDIES OF RIVAROXABAN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER HIP OR KNEE ARTHROPLASTY. 499–500. 2 indexed citations
4.
Turpie, Alexander G.G., Michael R. Lassen, Ajay K. Kakkar, et al.. (2009). POOLED ANALYSIS OF FOUR STUDIES OF RIVAROXABAN: EFFECT ON SYMPTOMATIC EVENTS AND BLEEDING AND THE INFLUENCE OF CLINICALLY RELEVANT PATIENT SUBGROUPS. CHEST Journal. 136(4). 144S–144S. 3 indexed citations
5.
Tuomilehto, Jaakko, Jaana Lindström, Martin Hellmich, et al.. (2009). Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus—The STOP-NIDDM risk-score. Diabetes Research and Clinical Practice. 87(2). 267–274. 32 indexed citations
6.
Hanefeld, M, Avraham Karasik, Carsta Koehler, Torsten Westermeier, & Jean‐Louis Chiasson. (2009). Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trial. Diabetes and Vascular Disease Research. 6(1). 32–37. 13 indexed citations
7.
8.
Balletshofer, Bernd, Kilian Rittig, M. Enderle, et al.. (2005). Intense Cholesterol Lowering Therapy with a HMG-CoA Reductase Inhibitor does not Improve Nitric Oxide Dependent Endothelial Function in Type-2-Diabetes. Experimental and Clinical Endocrinology & Diabetes. 113(6). 324–330. 23 indexed citations
9.
Bachmann, W. E., D. Petzinna, S. Raptis, Thomas C. Wascher, & Torsten Westermeier. (2003). Long-Term Improvement of Metabolic Control by Acarbose in Type 2 Diabetes Patients Poorly Controlled with Maximum Sulfonylurea Therapy. Clinical Drug Investigation. 23(10). 679–686. 14 indexed citations
10.
Minkov, Milen, Nicole Grois, Andreas Heitger, et al.. (2002). Response to initial treatment of multisystem langerhans cell histiocytosis: An important prognostic indicator. Medical and Pediatric Oncology. 39(6). 581–585. 85 indexed citations
11.
Minkov, Milen, Nicole Grois, Andreas Heitger, et al.. (2000). Treatment of Multisystem Langerhans Cell Histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 Studies. Klinische Pädiatrie. 212(4). 139–144. 69 indexed citations
12.
Schweden, F, et al.. (1998). Pulmonary nodules: detection with low-dose vs conventional-dose spiral CT. European Radiology. 8(4). 609–614. 50 indexed citations
13.
Westermeier, Torsten, Peter Kaatsch, Andreas Schoetzau, & J. Michaelis. (1998). Multiple primary neoplasms in childhood: data from the German children’s cancer registry. European Journal of Cancer. 34(5). 687–693. 31 indexed citations
14.
Fischer, Thomas, Andreas Neubauer, D. Huhn, et al.. (1998). Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied. Annals of Hematology. 77(1-2). 21–26. 7 indexed citations
15.
Kupferwasser, Iri, Harald Darius, Alexander Müller, et al.. (1998). Clinical and morphological characteristics inStreptococcus bovis endocarditis: a comparison with other causative microorganisms in 177 cases. Heart. 80(3). 276–280. 84 indexed citations
16.
Schweden, F, et al.. (1998). [Clinical relevance of thoracic CT in intensive care and emergency medicine].. PubMed. 8(6). 260–5. 1 indexed citations
17.
Eckardt, Volker F., G. Kanzler, & Torsten Westermeier. (1997). Complications and their impact after pneumatic dilation for achalasia: prospective long-term follow-up study. Gastrointestinal Endoscopy. 45(5). 349–353. 56 indexed citations
18.
Eckardt, V., et al.. (1997). Risk Factors for Diagnostic Delay in Achalasia. Digestive Diseases and Sciences. 42(3). 580–585. 74 indexed citations
19.
Westermeier, Torsten & J. Michaelis. (1995). Applicability of the Poisson distribution to model the data of the German Children's Cancer Registry. Radiation and Environmental Biophysics. 34(1). 7–11. 17 indexed citations
20.
Westermeier, Torsten, et al.. (1995). Prognostic factors of small-cell bronchial carcinoma. Lung Cancer. 12(1-2). 133–133.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shankar Kumar Breakdown of academic impact, for papers by Evangelos Messaris Breakdown of academic impact, for papers by T Scholten Breakdown of academic impact, for papers by Rosario Sánchez‐Martínez Breakdown of academic impact, for papers by Dmytro Khadzhynov Breakdown of academic impact, for papers by Luigi Fenoglio Breakdown of academic impact, for papers by M. Zanazzi Breakdown of academic impact, for papers by Frank A. Baciewicz Breakdown of academic impact, for papers by Laura M. Enomoto Breakdown of academic impact, for papers by Gerardo Bozovich
Rankless by CCL
2026